Anal Fissure Treatment Market Research Report - Global Forecast till 2030

Anal Fissure Treatment Market Research Report: Information, by Treatment Type (Medication and Surgery), Route of Administration (Oral and Topical), End User (Hospitals & Clinics and Research & Academic institutes) and Region (North America, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2030

ID: MRFR/Pharma/2553-CR | August, 2019 | Region : Global

1 Report Prologue

2 Market Introduction
2.1 Scope of Study 14
2.2 Research Objective 14
2.3 List of Assumptions 14
3 Research Methodology
3.1 Research Process 17
3.2 Primary Research 18
3.3 Secondary Research 19
3.4 Market Size Estimation 20
4 Market Dynamic
4.1 Introduction 22
4.2 Drivers 23
4.2.1 Increasing Pediatric and Geriatric Population 23
4.2.2 Growing Incidences of Constipation 23
4.2.3 Increasing Adoption of Unhealthy Lifestyle 23
4.2.4 Popularity of Over-the-Counter (OTD) Drugs 23
4.3 Restraints 24
4.3.1 Alternate Treatment Therapies 24
4.3.2 Declining Reimbursements 24
4.4 Opportunities 24
4.4.1 Entering Untapped Markets 24
5 Market Factor Analysis
5.1 Porter’s Five Forces Analysis 26
5.1.1 Bargaining Power of Suppliers 26
5.1.2 Bargaining Power of Buyers 27
5.1.3 Threat of New Entrants 27
5.1.4 Threat of Substitutes 27
5.1.5 Intensity of Rivalry 27
5.2 Value Chain Analysis 28
5.2.1 Primary Activities 28
5.2.2 Secondary Activities 28
6 Anal Fissure Treatment Market, by Treatment Type
6.1 Introduction 30
6.2 Medication 31
6.3 Surgery 32
7 Anal Fissure Treatment Market, by Route of Administration
7.1 Introduction 34
7.2 Oral 35
7.3 Topical 36
8 Anal Fissure Treatment Market, by End User
8.1 Introduction 38
8.2 Hospitals & Clinics 39
8.3 Research & Academic institutes 39
9 Global Anal Fissure Treatment Market, by Region
9.1 Introduction 41
9.2 Americas 43
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.1 North America 45
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.1.1 US 47
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.1.2 Canada 48
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.2.2 South America 49
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3 Europe 50
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1 Western Europe 52
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.1 Germany 54
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.2 UK 55
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.3 France 56
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.4 Italy 57
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.5 Spain 58
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.1.6 Rest of Western Europe 59
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.3.2 Eastern Europe 60
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4 Asia-Pacific 62
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.1 Japan 64
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.2 China 65
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.3 India 66
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.4 Australia 67
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.5 South Korea 68
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.4.6 Rest of Asia-Pacific 69
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
9.5 Rest of the World 71
Anal Fissure Treatment Market, by Treatment Type
Anal Fissure Treatment Market, by Route of Administration
Anal Fissure Treatment Market, by End User
10 Competitive Landscape
10.1 Introduction 73
11 Company Profiles
11.1 Pfizer Inc. 75
11.1.1 Company Overview 75
11.1.2 Financial Overview 75
11.1.3 Products/Services Offered 76
11.1.4 Key Developments 76
11.1.5 SWOT Analysis 76
11.1.6 Key Strategies 76
11.2 Teva Pharmaceutical Industries Ltd 77
11.2.1 Company Overview 77
11.2.2 Financial Overview 77
11.2.3 Products/Services Offered 78
11.2.4 Key Developments 78
11.2.5 SWOT Analysis 78
11.2.6 Key Strategies 78
11.3 GlaxoSmithKline Plc 79
11.3.1 Company Overview 79
11.3.2 Financial Overview 79
11.3.3 Products/Services Offered 80
11.3.4 Key Developments 80
11.3.5 SWOT Analysis 80
11.3.6 Key Strategies 80
11.4 Cook 81
11.4.1 Company Overview 81
11.4.2 Financial Overview 81
11.4.3 Products/Services Offered 81
11.4.4 SWOT Analysis 81
11.4.5 Key Developments 81
11.4.6 Key Strategies 81

11.5 Cigna 82
11.5.1 Company Overview 82
11.5.2 Financial Overview 82
11.5.3 Products/Services Offered 83
11.5.4 SWOT Analysis 83
11.5.5 Key Developments 83
11.5.6 Key strategy 83
11.6 Eisai Co. Ltd. 84
11.6.1 Company Overview 84
11.6.2 Financial Overview 84
11.6.3 Products/Services Offered 85
11.6.4 Key Developments 85
11.6.5 SWOT Analysis 85
11.6.6 Key Strategies 85
11.7 Abbott Laboratories 86
11.7.1 Company Overview 86
11.7.2 Financial Overview 86
11.7.3 Products/Services Offered 87
11.7.4 Key Developments 87
11.7.5 SWOT Analysis 87
11.7.6 Key strategy 88
11.8 Bayer AG 89
11.8.1 Company Overview 89
11.8.2 Financial Overview 89
11.8.3 Products/Services Offered 90
11.8.4 Key Developments 90
11.8.5 SWOT Analysis 90
11.8.6 Key Strategies 90
11.9 AstraZeneca 91
11.9.1 Company Overview 91
11.9.2 Financial Overview 91
11.9.3 Products/Services Offered 92
11.9.4 Key Developments 92
11.9.5 SWOT Analysis 92
11.9.6 Key Strategies 92
11.10 Allergan Inc. 93
11.10.1 Company Overview 93
11.10.2 Financial Overview 93
11.10.3 Products/Services Offered 94
11.10.4 Key Developments 94
11.10.5 SWOT Analysis 94
11.10.6 Key Strategies 94
11.11 Valeant Pharmaceuticals International Inc. 95
11.11.1 Company Overview 95
11.11.2 Financial Overview 95
11.11.3 Products/Services Offered 96
11.11.4 Key Developments 96
11.11.5 SWOT Analysis 96
11.11.6 Key Strategies 96
11.12 Taro Pharmaceutical Industries Ltd 97
11.12.1 Company Overview 97
11.12.2 Financial Overview 97
11.12.3 Products/Services Offered 98
11.12.4 Key Developments 98
11.12.5 SWOT Analysis 98
11.12.6 Key Strategies 98
12 Appendix
12.1 Discussion Blue Print 100
13 List of Tables
TABLE 1 LIST OF ASSUMPTIONS 14
TABLE 2 PRIMARY INTERVIEWS 17
TABLE 3 GLOBAL ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 30
TABLE 4 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR MEDICATION 2020–2027 (USD MILLION) 31
TABLE 5 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR SURGERY 2020–2027 (USD MILLION) 32
TABLE 6 GLOBAL ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 34
TABLE 7 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR ORAL 2020–2027 (USD MILLION) 35
TABLE 8 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR TOPICAL 2020–2027 (USD MILLION) 36
TABLE 9 GLOBAL ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 38
TABLE 10 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR HOSPITALS & CLINICS 2020–2027 (USD MILLION) 39
TABLE 11 GLOBAL ANAL FISSURE TREATMENT MARKET BY REGION, FOR HOSPITALS & CLINICS 2020–2027 (USD MILLION) 39
TABLE 12 GLOBAL ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 41
TABLE 13 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 43
TABLE 14 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 43
TABLE 15 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 44
TABLE 16 AMERICAS: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 44
TABLE 17 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY COUNTRY 2020–2027 (USD MILLION) 45
TABLE 18 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 45
TABLE 19 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 46
TABLE 20 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 46
TABLE 21 US ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 47
TABLE 22 US: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 47
TABLE 23 US: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 47
TABLE 24 CANADA ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 48
TABLE 25 CANADA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 48
TABLE 26 CANADA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 48
TABLE 27 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 49
TABLE 28 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 49
TABLE 29 SOUTH AMERICA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 49
TABLE 30 EUROPE: ANAL FISSURE TREATMENT MARKET, BY REGION 2020–2027 (USD MILLION) 50
TABLE 31 EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 50
TABLE 32 EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 51
TABLE 33 EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 51
TABLE 34 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY COUNTRY/REGION 2020–2027 (USD MILLION) 52
TABLE 35 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 53
TABLE 36 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 53
TABLE 37 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 53
TABLE 38 GERMANY: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 54
TABLE 39 GERMANY: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 54
TABLE 40 GERMANY: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 54
TABLE 41 UK: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 55
TABLE 42 UK: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 55
TABLE 43 UK: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 55
TABLE 44 FRANCE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 56
TABLE 45 FRANCE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 56
TABLE 46 FRANCE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 56
TABLE 47 ITALY: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 57
TABLE 48 ITALY: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 57
TABLE 49 ITALY: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 57
TABLE 50 SPAIN: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 58
TABLE 51 SPAIN: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 58
TABLE 52 SPAIN: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 58
TABLE 53 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 59
TABLE 54 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
2020–2027 (USD MILLION) 59
TABLE 55 REST OF WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 60
TABLE 56 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 60
TABLE 57 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 60
TABLE 58 EASTERN EUROPE: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 61
TABLE 59 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY COUNTRY/REGION 2020–2027 (USD MILLION) 62
TABLE 60 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 63
TABLE 61 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 63
TABLE 62 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 63
TABLE 63 JAPAN: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 64
TABLE 64 JAPAN: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 64
TABLE 65 JAPAN: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 64
TABLE 66 CHINA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 65
TABLE 67 CHINA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 65
TABLE 68 CHINA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 65
TABLE 69 INDIA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 66
TABLE 70 INDIA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 66
TABLE 71 INDIA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 66
TABLE 72 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 67
TABLE 73 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 67
TABLE 74 AUSTRALIA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 67
TABLE 75 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 68
TABLE 76 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 68
TABLE 77 SOUTH KOREA: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 68
TABLE 78 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 69
TABLE 79 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 69
TABLE 80 REST OF ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 70
TABLE 81 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020–2027 (USD MILLION) 71
TABLE 82 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020–2027 (USD MILLION) 71
TABLE 83 REST OF THE WORLD: ANAL FISSURE TREATMENT MARKET, BY END USER 2020–2027 (USD MILLION) 71
TABLE 84 TOP PLAYERS IN THE GLOBAL ANAL FISSURE TREATMENT MARKET 73
14 List of Figures
FIGURE 1 GLOBAL ANAL FISSURE TREATMENT MARKET: MARKET STRUCTURE 15
FIGURE 2 RESEARCH PROCESS 17
FIGURE 3 TOP-DOWN AND BOTTOM-UP APPROACH 20
FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ANAL FISSURE TREATMENT MARKET 22
FIGURE 5 VALUE CHAIN 28
FIGURE 6 GLOBAL ANAL FISSURE TREATMENT MARKET, BY TREATMENT TYPE 2020 & 2027 (USD MILLION) 31
FIGURE 7 GLOBAL ANAL FISSURE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020 & 2027 (USD MILLION) 35
FIGURE 8 GLOBAL ANAL FISSURE TREATMENT MARKET, BY END USER 2020 & 2027 (USD MILLION) 38
FIGURE 9 GLOBAL ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 42
FIGURE 10 AMERICAS: ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 43
FIGURE 11 NORTH AMERICA: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY 2020 (%) 45
FIGURE 12 EUROPE: ANAL FISSURE TREATMENT MARKET SHARE, BY REGION 2020 (%) 50
FIGURE 13 WESTERN EUROPE: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY/REGION 2020 (%) 52
FIGURE 14 ASIA-PACIFIC: ANAL FISSURE TREATMENT MARKET SHARE, BY COUNTRY/REGION 2020 (%) 62

Anal Fissure Treatment Market

Anal Fissure Treatment Market is estimated to grow at a 8.20% CAGR and is expected to reach USD 2,526.5 Million by 2030

Segmentation

By Treatment Type Medication Surgery
By Route of Administration Oral Topical
End User Hospitals & Clinics Research & Academic institutes

Key Players

  • Abbott Laboratories
  • GlaxoSmithKline Plc
  • Valeant Pharmaceuticals
  • Eisai Co. Ltd.
  • Taro Pharmaceutical Industries Ltd. Cook
  • Pfizer Inc.
  • AstraZeneca
  • Bayer AG
  • Allergan Inc.
  • Novasep
  • Geri-care Pharmaceuticals

Drivers

  • Increasing adoption of unhealthy lifestyles and fast food consumption
  • Childbirth trauma among women
Speak to Analyst Request a Free Sample

Global Anal Fissure Treatment Market: Competitive Landscape


The global anal fissure treatment market is characterized by the presence of many global, regional, and local players. The market is competitive with all players competing to gain a presence in the market. Intense competition, rapid advances in technology, frequent changes in government policies, and regulations are key factors that confront market growth. The manufacturers compete based on cost, quality, and reliability. It is decisive for manufacturers to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.


The growth of market players is dependent on market conditions, government support, and industry development. Thus, manufacturers should focus on expanding geographically and improving their products. They primarily focus on the development of novel products. Although international players are dominating the market, regional and foreign players with small market shares also have a presence. The international players are likely to strengthen their presence worldwide through acquisitions during the forecast period. It has also been forecast that the improvement of the global economic scenario combined with efforts to enhance the infrastructure in emerging nations, is fueling the market growth, thereby making it an ideal time for new products and increase the global market share.


The players with better technical and financial resources could develop innovative products. Further, research and development would play a major role in the development of players in the market. Therefore, manufacturers must develop new technologies and stay abreast of emerging technologies that could affect the continuing competitiveness of their products and services in the market.